Safety and efficacy of semaglutide once weekly vs sitagliptin once daily, both as monotherapy in Japanese people with type 2 diabetes

AIMS: To assess the safety and efficacy of monotherapy with once‐weekly subcutaneous (s.c.) semaglutide vs sitagliptin in Japanese people with type 2 diabetes (T2D). METHODS: In this phase IIIa randomized, open‐label, parallel‐group, active‐controlled, multicentre trial, Japanese adults with T2D tre...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Diabetes Obes Metab
Auteurs principaux: Seino, Yutaka, Terauchi, Yasuo, Osonoi, Takeshi, Yabe, Daisuke, Abe, Nobuyuki, Nishida, Tomoyuki, Zacho, Jeppe, Kaneko, Shizuka
Format: Artigo
Langue:Inglês
Publié: Blackwell Publishing Ltd 2017
Sujets:
Original Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5813234/
https://ncbi.nlm.nih.gov/pubmed/28786547
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13082
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires